In recent years, some medical institutions have been exposed for using fear tactics—such as falsely claiming a patient’s condition is ‘on the verge of cancer’—to pressure them into undergoing expensive and often unnecessary surgeries. These practices typically involve doctors exaggerating risks, misrepresenting benign conditions as highly suspicious or imminent malignancies, thereby inducing anxiety and pushing patients toward costly procedures. In several reported cases, postoperative pathology results showed no evidence of cancer, raising serious concerns about medical ethics and integrity.Such conduct not only violates Chinese regulations—including the Physician Law and the Administrative Regulations on Medical Institutions—which mandate truthful disclosure of diagnoses and respect for patients’ rights to informed consent and autonomous decision-making, but may also constitute fraud or overtreatment. China’s National Health Commission has repeatedly emphasized cracking down on ‘coercive or misleading medical practices’ and promoting transparent, standardized clinical protocols. Experts advise patients facing serious diagnoses to seek second opinions, retain all medical records, and file complaints through official channels if needed. Strengthening regulatory oversight and improving complaint mechanisms are essential steps to curb such unethical practices.
近年来，个别医疗机构被曝出以‘癌变’为由恐吓患者，诱导其接受高价甚至不必要的手术。此类行为通常表现为：医生夸大病情风险，将良性病变描述为‘即将癌变’或‘高度疑似癌症’，制造患者恐慌情绪，进而推动其接受费用高昂的手术治疗。部分案例中，患者术后病理报告显示并无恶性肿瘤，引发对医疗诚信和伦理的严重质疑。这种做法不仅违反了《中华人民共和国医师法》和《医疗机构管理条例》中关于如实告知病情、尊重患者知情权与选择权的规定，也涉嫌构成欺诈或过度医疗。国家卫健委多次强调要整治‘诱导式医疗’，并推动建立透明、规范的诊疗流程。专家建议，患者在面对重大诊断时应寻求第二诊疗意见，保留病历资料，并通过正规渠道维权。同时，加强医疗监管、完善投诉机制，是遏制此类乱象的关键措施。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/2442.html